Home/Filings/4/0001193125-26-018126
4//SEC Filing

Badawi Paul 4

Accession 0001193125-26-018126

CIK 0001531177other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:54 PM ET

Size

6.5 KB

Accession

0001193125-26-018126

Research Summary

AI-generated summary of this filing

Updated

Sight Sciences (SGHT) 10% Owner Paul Badawi Sells 22,362 Shares

What Happened Paul Badawi, reported as a 10% owner of Sight Sciences (SGHT), sold 22,362 shares of common stock on 2026-01-16 in open-market/private-sale transactions. The sale generated approximately $148,036 using a weighted average price of $6.62 per share. This was a sale to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs), not a purchase signal.

Key Details

  • Transaction date: 2026-01-16; Form 4 filed 2026-01-21 (filed 5 days after the transaction).
  • Shares sold: 22,362; weighted average price $6.62; total proceeds ≈ $148,036.
  • Price range: shares sold in multiple transactions at prices from $6.44 to $6.69 (per footnote F2).
  • Purpose: Sale made to cover tax liability in connection with RSU vesting (footnote F1).
  • Shares beneficially owned after the transaction: 6,025,840 total (includes 5,517,778 outstanding shares + 508,062 RSUs that have not yet vested) (footnote F3).
  • Prior reporting notes: filing corrects earlier reporting omissions related to past RSU grants and excludes certain option shares as explained in footnote F4.
  • Transaction code: S (Sale); functionally a tax-withholding sale (F).

Context

  • Tax-withholding sales tied to RSU vesting are common and often routine; they do not necessarily indicate a change in insider sentiment.
  • As a 10% owner, Badawi’s holdings are substantial; this sale was a small, administrative disposition relative to total reported beneficial ownership.
  • The Form 4 was filed five days after the transaction date, which exceeds the typical 2-business-day reporting window and may indicate a late filing.

Insider Transaction Report

Form 4
Period: 2026-01-16
Badawi Paul
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Common Stock

    [F1][F2][F3][F4]
    2026-01-16$6.62/sh22,362$148,0366,025,840 total
Footnotes (4)
  • [F1]Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
  • [F2]Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Includes (i) 5,517,778 shares of common stock, and (ii) 508,062 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested.
  • [F4]The Reporting Person previously reported a grant of 87,800 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 176,600 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 176,500 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares. Furthermore, the Reporting Person's Form 4 filed on February 16, 2024 inadvertently included under Column 5 of Table I 53,574 shares of common stock underlying the Reporting Person's stock options that were to vest within 60 days of the date of such filing. The reported balance on this Form 4 excludes the number of shares underlying such stock options.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for Paul Badawi|2026-01-21

Documents

1 file

Issuer

Sight Sciences, Inc.

CIK 0001531177

Entity typeother

Related Parties

1
  • filerCIK 0001870865

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:54 PM ET
Size
6.5 KB